Matt Kalaycio, M.D.
| Appointed: |
1994 |
| Gender: |
Male |
| Languages: |
English |
Hematologic Oncology and Blood Disorders
Transplantation Center
Biographical Sketch
Matt Kalaycio, MD, FACP, is Director of the Chronic Leukemia and Myeloma Program at the Taussig Cancer Institute at Cleveland Clinic's main campus. Dr. Kalaycio holds a joint appointment in the Cleveland Clinic's Transplant Center and is a Staff member in the Department of Hematologic Malignancies and Blood Disorders, in addition to being a Professor in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. Board-certified in hematology, medical oncology and internal medicine, Dr. Kalaycio's clinical interests are in leukemia and stem cell transplantation.
Dr. Kalaycio has been published in numerous scientific publications including Bone Marrow Transplantation, Journal of Clinical Oncology, and Leukemia. He also is the editor of a book on leukemia and co-editor of a book on clinical malignant hematology. His research interests focus on testing new treatments for leukemia.
Dr. Kalaycio received his degree from West Virginia University School of Medicine in Morgantown. He completed his residency in internal medicine at Mercy Hospital of Pittsburgh and fellowships in hematology and medical oncology and bone marrow transplantation at Cleveland Clinic.
Education & Fellowships
| Medical School: | West Virginia University School of Medicine, Morgantown, WV |
|
| Internship: | Mercy Hospital of Pittsburgh, Medical Internship, Pittsburgh, PA |
| Residency: | Mercy Hospital of Pittsburgh, Internal Medicine, Pittsburgh, PA |
| Fellowship: | Cleveland Clinic, Hematology, Cleveland, OH |
| Fellowship: | Cleveland Clinic, Medical Oncology, Cleveland, OH |
| Other Education: | (Undergraduate) Cornell University, Ithaca, NY |
Certifications
Medical Oncology
Hematology
Internal Medicine
Specialty Interests
Bone Marrow Transplantation, Leukemia, Multiple Myeloma.
Awards & Honors
- Castle Connelly's "America's Top Doctors"
- Best Doctors' "Best Doctors in America"
- Fellow, American College of Physicians
Professional Memberships
- American Society of Hematology
- American Society of Clinical Oncology
- American College of Physicians
- Southwest Oncology Group
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its doctors’ connections with industry and those of their immediate family members. As of 7/31/2008, Dr. Kalaycio has reported the financial relationships with the companies listed below. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
Consulting. Dr. Kalaycio receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
- Bristol-Myers Squibb Company
- Celegene Corporation
- Cephalon, Inc.
- Novartis
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
